Haixia Su
Chinese Academy of Sciences(CN)Chinese Academy of Sciences(CN)Shanghai Institute of Materia Medica(CN)Gansu Provincial Hospital(CN)University of Chinese Academy of Sciences(CN)
Publications by Year
Research Areas
Computational Drug Discovery Methods, SARS-CoV-2 and COVID-19 Research, Synthesis and biological activity, Fault Detection and Control Systems, Viral Infections and Immunology Research
Most-Cited Works
- → Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease(2020)1,583 cited
- → Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir(2020)1,283 cited
- → Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease(2021)190 cited
- → Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro(2020)146 cited
- → Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir(2020)138 cited
- → What coronavirus 3C‐like protease tells us: From structure, substrate selectivity, to inhibitor design(2021)128 cited